M. Gaga (Athens, Greece), A. Bergner (Munich, Germany)
Prognostic significance of Nestin in resected non-small cell lung cancer
S. Ryuge, Y. Sato, G. Wang, M. Yokoba, M. Katagiri, N. Masuda (Sagamihara, Japan)
|  |
EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
R. Cherneva, O. Georgiev, D. Petrova, B. Rukova, D. Toncheva (Toncheva, Bulgaria)
|  |
EGF-receptor mutation in non-small cell lung cancer – Experiences by routine molecular testing in a German lung cancer centre
W. Grüning, T. Mairinger, J. Kollmeier, T. Blum, S. Griff, A. Roth, S. Stephan-Falkenau, T. Bauer (Berlin, Germany)
| |
Detection of k-ras mutations in cytologic specimen of lung cancer patients as predictive factor of targeted therapy
T. Mundt, R. Dück, S. Gütz (Leipzig, Germany)
| |
Her/2 neu and p53 expression in patients with non-small cell lung cancer predict shortened survival
B. Ilievska Poposka, B. Zafirova, S. Jovanovska Crvenkovska, G. Petrusevska (Skopje, Fyrom)
| |
Diagnostic markers of lung cancer in bronquial fluid: Development of inmunoassays and validation
S. Pedrero, N. Marina, A. Gomez, B. Ruiz-Argüello, M. Uribarri, J. Algorta, S. Carrera, G. López Vivanco, R. Zalacain (Barakaldo, Zamudio, Spain)
| |
Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer
Y. L. Lee, W. Chen, W. E. Cheng, S. C. Chen, C. M. Shih (Taichung, Taiwan)
| |
Serum napsin A as a tumor marker for primary lung adenocarcinoma
T. Hamada, T. Samukawa, G. Tsukuya, K. Ohara, Y. Soejima, H. Nagahama, M. Yanagi, H. Tsubouchi (Kagoshima, Japan)
| |
Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance
R. Cherneva, O. Georgiev, D. Petrova, M. Stamenova, N. Trifonova (Sofia, Bulgaria)
| |
Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results
K. Samara, G. Soufla, E. Vassalou, K. Karagiannis, N. Siafakas, K. Antoniou (Heraklion, Greece)
| |
Clinical significance of MMP-9 and their tissue inhibitor TIMP-2 in lung adenocarcinomas ongoing study
E. Boutsikou, T. Kontakiotis, G. Galaktidou, E. Eleftheriadou, P. Zarogoulidis, V. Tzarou, K. Zarogoulidis (Thessaloniki, Greece)
| |
Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data
A. Muñoz Lucas, M. Caamaño Somoza, J. Jareño Esteban, I. de Granda Orive, B. Carrillo Aranda, J. A. Maldonado Sanz, A. Aguilar Ros, C. Civera Tejuca, J. L. Lopez Colon, L. M. Callol Sanchez (Madrid, Spain)
| |
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis
M. Petrovic, N. Ilic, I. Cekerevac, L. Novkovic, V. Radulovic, V. Cupurdija (Kragujevac, Republic Of Serbia)
| |
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer
Y. Zhou, X. Tan, Y. Li, W. Huang, X. Cai, Q. Zeng (Guangzhou, China)
| |
The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron- specific enolase in patients with advanced non-small-cell lung cancer
M. Petovic, Z. Lazic, I. Cekerevac, L. Novkovic, V. Cupurdija (Kragujevac, Republic Of Serbia)
| |
Plasma levels of alpha crystalline antibodies in NSCLC patients – Diagnostic significance
R. Cherneva, O. Georgiev, D. Petrova, M. Stamenova, N. Trifonova (Sofia, Bulgaria)
| |
Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
I. Tsilioni, T. Kerenidi, M. Lada, S. Oikonomidi, T. Kiropoulos, K. Gourgoulianis (Larissa, Greece)
| |
Abnormal expression of let-7a miRNA in blood of lung cancer patient
H. C. Jeong, E. K. Kim, J. H. Lee, J. M. Lee, J. K. Kim (Seongnam, Republic Of Korea)
| |
Metabolomics in lung cancer
S. Okamoto, K. Kobayashi, S. Nishiumi, M. Yoshida, Y. Nishimura (Japan)
| |
Bone metabolic markers in detecting bone metastasis of lung cancer
S. Bilgin Bayrak, E. Ceylan, M. Serter, F. Karadag, E. Demir, O. Çildag (Aydin, Turkey)
| |